This site has just undergone scheduled maintenance in order to be moved to a new infrastructure. You shouldn’t experience any change, but do let us know (datacentre@scilifelab.se) if you think anything looks out of place.

Mangsbo SM

JSON
CSV
XLSX
TXT
Family name Mangsbo
Given name Sara M
Initials SM
ORCID

ORCID 0000-0002-1355-2678
Affiliations Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

4 publications

PubMed DOI Crossref
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.
Laurén I, Havervall S, Ng H, ..., Thålin C, Mangsbo S
Immun Inflamm Dis 10 (4) e595 [2022-04-00; online 2022-03-30]
Autoimmunity and Serology Profiling [Collaborative]
PubMed DOI Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C
J. Intern. Med. 291 (1) 72-80 [2022-01-00; online 2021-09-27]
Affinity Proteomics Uppsala [Service] Autoimmunity and Serology Profiling [Collaborative]
PubMed DOI Crossref
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
Mangsbo SM, Havervall S, Laurén I, ..., Klingström J, Thålin C
PLoS ONE 16 (9) e0258041 [2021-09-30; online 2021-09-30]
Autoimmunity and Serology Profiling [Technology development]
PubMed DOI Crossref
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
Kerzeli IK, Lord M, Doroszko M, ..., Segersten U, Mangsbo SM
PLoS ONE 16 (7) e0253178 [2021-07-07; online 2021-07-07]
Affinity Proteomics Uppsala [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]
SciLifeLab Data Centre
Publications 9.5.1